Tatva Chintan Pharma Chem lists with 95% gain on BSE

Our Bureau Chennai | Updated on July 29, 2021

The IPO was subscribed 180.35 times, the second-largest in 2021.

Shares of Tatva Chintan Pharma Chem made a debut with a bang on Thursday. The stock listed with 95 per cent gains on the BSE at ₹2,111.80 as against the issue price of ₹1,082.

The initial public offering of Tatva Chintan Pharma Chem was subscribed 180.35 times, the second-largest in 2021 behind MTAR Technologies, whose IPO subscribed over 200 times.

While the portion reserved for retail investors was subscribed 35.34 times, the non-institutional investors’ quota received bids worth 512.22 times. The qualified institutional buyers’ portion received bids worth 185.23 times.

The IPO consists of a fresh issue worth ₹225 crore and an offer for the sale of shares worth ₹275 crore by the promoter group. The company fixed the IPO price at ₹1,083, the upper end of the ₹1,073-1,083 price band.

The company had raised ₹150 crore from anchor investors ahead of the issue.

Published on July 29, 2021

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like